Viewing Study NCT00136695



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00136695
Status: COMPLETED
Last Update Posted: 2022-09-13
First Post: 2005-08-25

Brief Title: Anastrozole Administration in Elderly Hypogonadal Men
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Study Overview

Official Title: Anastrozole Administration in Elderly Hypogonadal Men
Status: COMPLETED
Status Verified Date: 2022-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to assess the effects of sustained aromatase inhibitor therapy to reduce estrogen levels in elderly men with mild hypogonadism a decreased level of sex hormones
Detailed Description: It has long been accepted that aging in men is associated with a slow steady decline in gonadal androgen male sex hormone production Several studies have explored androgen replacement but the safety and efficacy of testosterone administration remains controversial Aromatase inhibitors may provide a particularly useful way to restore normal androgen production in aging men

This study will recruit 150 male volunteers 60 years of age or older to be randomized to receive either anastrozole or a placebo for 24 months Six visits are planned over the 96-week treatment period

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
1R01AG025099-1A1 US NIH GrantContract None httpsreporternihgovquickSearch5R01AG025099-05
5R01AG025099-05 NIH None None